Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionDoheny Asset Management /ca
Latest Disclosed Ownership1,216 shares
Latest Disclosed Value $ 428
Doheny Asset Management /ca ownership in AMGN / Amgen Inc.

On May 7, 2026 - Doheny Asset Management /ca filed a 13F-HR form disclosing ownership of 1,216 shares of Amgen Inc. (CH:AMGN) valued at $428 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,216 shares of Amgen Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F AMGEN COM 031162100 1,216 0 0.00 0 0.2790
2026-02-11 2025-12-31 13F AMGEN COM 031162100 1,216 -34 -2.72 0 0.2430
2025-11-12 2025-09-30 13F AMGEN COM 031162100 1,250 0 0.00 0 0.2240
2025-08-14 2025-06-30 13F AMGEN COM 031162100 1,250 -505 -28.77 0 0.2445
2025-05-14 2025-03-31 13F AMGEN COM 031162100 1,755 0 0.00 1 0.4283
2025-02-10 2024-12-31 13F AMGEN COM 031162100 1,755 -100 -5.39 0 0.3411
2024-11-14 2024-09-30 13F AMGEN COM 031162100 1,855 -100 -5.12 1 0.4083
2024-08-15 2024-06-30 13F/A-1 AMGEN COM 031162100 1,955 0 0.00 1 0.4353
2024-08-07 2024-06-30 13F AMGEN COM 031162100 3,796 1,841 1 0.8458
2024-05-08 2024-03-31 13F AMGEN COM 031162100 1,955 -50 -2.49 1 0.4570
2024-02-06 2023-12-31 13F AMGEN COM 031162100 2,005 0 0.00 1 0.5651
2023-11-08 2023-09-30 13F AMGEN COM 031162100 2,005 -500 -19.96 1 0.5225
2023-08-08 2023-06-30 13F AMGEN COM 031162100 2,505 0 0.00 1 0.4765
2023-05-16 2023-03-31 13F AMGEN COM 031162100 2,505 250 11.09 1 0.5441
2023-02-14 2022-12-31 13F AMGEN COM 031162100 2,255 -350 -13.44 1 -100.00 0.6867
2022-11-10 2022-09-30 13F AMGEN COM 031162100 2,605 100 3.99 587 -3.14 0.5881
2022-05-16 2022-03-31 13F AMGEN COM 031162100 2,505 -300 -10.70 606 -3.96 0.4421
2022-02-15 2021-12-31 13F AMGEN COM 031162100 2,805 -20 -0.71 631 4.99 0.4423
2021-10-22 2021-09-30 13F AMGEN COM 031162100 2,825 0 0.00 601 -12.77 0.4298
2021-08-10 2021-06-30 13F AMGEN COM 031162100 2,825 -580 -17.03 689 -18.65 0.4436
2021-05-17 2021-03-31 13F AMGEN COM 031162100 3,405 -120 -3.40 847 4.57 0.5742
2021-02-26 2020-12-31 13F AMGEN COM 031162100 3,525 -71 -1.97 810 -11.38 0.5630
2020-11-12 2020-09-30 13F/A-1 AMGEN COM 031162100 3,596 -200 -5.27 914 2.12 0.7553
2020-11-12 2020-09-30 13F AMGEN COM 031162100 4,066 270 980 776,631.3220
2020-08-18 2020-06-30 13F/A-1 AMGEN COM 031162100 3,796 -270 -6.64 895 -8.67 0.8458
2020-08-17 2020-06-30 13F AMGEN COM 031162100 4,066 0 980 776,631.3220
2020-05-14 2020-03-31 13F AMGEN COM 031162100 4,066 0 0.00 980 0.00 0.7766
2020-02-11 2019-12-31 13F AMGEN COM 031162100 4,066 -150 -3.56 980 20.10 0.7766
2019-11-15 2019-09-30 13F AMGEN COM 031162100 4,216 -2,985 -41.45 816 -38.51 0.7084
2019-08-14 2019-06-30 13F AMGEN COM 031162100 7,201 2,790 63.25 1,327 58.35 1.1100
2019-05-14 2019-03-31 13F AMGEN COM 031162100 4,411 0 0.00 838 -2.44 0.7126
2019-02-13 2018-12-31 13F AMGEN COM 031162100 4,411 -2,160 -32.87 859 -36.93 0.6289
2018-11-14 2018-09-30 13F AMGEN COM 031162100 6,571 0 0.00 1,362 12.28 0.7127
2018-08-10 2018-06-30 13F AMGEN COM 031162100 6,571 -800 -10.85 1,213 -3.50 0.6576
2018-05-16 2018-03-31 13F AMGEN COM 031162100 7,371 -300 -3.91 1,257 -5.77 0.6599
2018-02-15 2017-12-31 13F AMGEN INC. DUTCH TENDER EXP: 0 COM 031162100 7,671 105 1.39 1,334 -5.46 0.6218
2017-11-13 2017-09-30 13F AMGEN INC COM COM 031162100 7,566 0 0.00 1,411 8.29 0.6489
2017-08-14 2017-06-30 13F AMGEN COM 031162100 7,566 0 0.00 1,303 5.00 0.6110
2017-05-10 2017-03-31 13F AMGEN COM 031162100 7,566 0 0.00 1,241 12.21 0.5606
2017-02-08 2016-12-31 13F AMGEN COM 031162100 7,566 -3,187 -29.64 1,106 -38.35 0.5355
2016-11-15 2016-09-30 13F AMGEN COM 031162100 10,753 -30 -0.28 1,794 9.32 0.9216
2016-08-10 2016-06-30 13F AMGEN COM 031162100 10,783 865 8.72 1,641 10.36 0.8239
2016-05-13 2016-03-31 13F AMGEN COM 031162100 9,918 150 1.54 1,487 -6.24 0.7668
2016-02-09 2015-12-31 13F AMGEN COM 031162100 9,768 -150 -1.51 1,586 15.60 0.7751
2015-11-17 2015-09-30 13F AMGEN COM 031162100 9,918 25 0.25 1,372 -9.68 0.7110
2015-08-14 2015-06-30 13F AMGEN COM 031162100 9,893 1,713 20.94 1,519 16.13 0.6792
2015-05-15 2015-03-31 13F AMGEN COM 031162100 8,180 -75 -0.91 1,308 -0.53 0.6064
2015-02-12 2014-12-31 13F AMGEN COM 031162100 8,255 0 0.00 1,315 13.46 0.6285
2014-11-13 2014-09-30 13F AMGEN COM 031162100 8,255 5,605 211.51 1,159 269.11 0.5797
2014-08-07 2014-06-30 13F AMGEN COM 031162100 2,650 0 0.00 314 -3.98 0.1486
2014-05-09 2014-03-31 13F AMGEN COM 031162100 2,650 2,650 327 0.1681
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.